Publication:
Imatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia

Simple item page
dc.contributor.authorsBizargity, P; Adiguzel, C; Ozilhan, G; Bayik, M; Eksioglu-Demiralp, E
dc.date.accessioned2022-04-25T00:10:16Z
dc.date.accessioned2026-01-11T18:11:46Z
dc.date.available2022-04-25T00:10:16Z
dc.date.issued2005
dc.identifier.doi10.1111/j.1365-2257.2004.00657.x
dc.identifier.issn0141-9854
dc.identifier.pubmed15686514
dc.identifier.urihttps://hdl.handle.net/11424/263639
dc.identifier.wosWOS:000226705100013
dc.languageeng
dc.publisherWILEY
dc.relation.ispartofCLINICAL AND LABORATORY HAEMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPROTEIN-KINASE-C
dc.subjectNADPH OXIDASE
dc.subjectP47(PHOX)
dc.subjectPHOSPHORYLATION
dc.subjectACTIVATION
dc.titleImatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia
dc.typeother
dc.type.subletter
dspace.entity.typePublication
oaire.citation.endPage80
oaire.citation.issue1
oaire.citation.startPage79
oaire.citation.titleCLINICAL AND LABORATORY HAEMATOLOGY
oaire.citation.volume27

Files

Collections

Araştırma Çıktıları